Each medication comes in at around $400 per month
In clinical trials, severe gastrointestinal adverse reactions were reported more frequently among patients who received semaglutide tablets (7 mg 0.6%, 14 mg 2%) than placebo (0.3%)
These effects are typically mild to moderate and tend to diminish over time with continued use and gradual dose escalation
Tirzepatide is an FDA- and EMA-approved dual GIP/GLP-1 receptor agonist with multiple completed Phase 3 trials behind it
Of course, always make sure to speak with your healthcare provider before making any changes
The most common side effects found in Wegovy clinical trials were gastrointestinal, including nausea, vomiting diarrhea, constipation and abdominal pain, said both Ur and Wharton